A Clinical Trial of YH23537 in Patients With Knee Osteoarthritis

A Randomized, Double-blind, Placebo- and Active-Controlled, Multicenter, Phase 2 Trial to Evaluate the Efficacy and Safety of YH23537 in Patients With Osteoarthritis of the Knee

The purpose of this study is to evaluate efficacy and safety of YH23537 versus celebrex in patients with knee osteoarthritis.

Inclusion Criteria:

• Signed Informed Consent
• Men and women ≥ 40 years of age
• Patients with knee osteoarthritis at one or both knee by ACR

Exclusion Criteria:

• Patients with known or suspected secondary knee osteoarthritis
• Other exclusions applied